Abstract
Background
The use of indwelling central venous catheters (CVCs) for chemotherapy delivery is common practice in cancer patients. Central venous lines facilitate ease of blood drawing along with administration of blood products and various other therapies. Significant risks, however, include infection and catheter-related thrombosis. Several attempts have been investigated to reduce CVC-associated thrombosis, in particular anticoagulation strategies. Given the lack of clear efficacy, there is at present no recommendation for the use of prophylactic anti-coagulation in patients with solid malignancy and an indwelling CVC.
Materials and methods
This paper reviews recent given recommendations based on controlled trials.
Similar content being viewed by others
References
Trousseau A, Bazire V, Cormack JR (1867) Clinique medicale de l’Hotel-Dieu, Lectures on clinical medicine. Hardwicke, London
Verso M, Agnelli G (2003) Venous thromboembolism associated with longterm use of central venous catheters in cancer patients. J Clin Oncol 21(19):3665–75
Anderson AJ (1989) Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 95(1):71–75
Bern MM (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 112(6):423–428
Lokich JJ, Becker B (1983) Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 52(9):1586–89
Lokich JJ (1985) Complications and management of implanted venous access catheters. J Clin Oncol 3(5):710–717
Oakley GJ (1990) Symptomatic central venous thrombosis and long-term right atrial catheters. Gynecol Oncol 36(3):405–408
Bona RD (2003) Central line thrombosis in patients with cancer. Curr Opin Pulm Med 9(5):362–366
Tesselaar ME (2004) Risk factors for catheter-related thrombosis in cancer patients. Eur J Cancer 40(15):2253–2259
Lee AY (2006) Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 24(9):1404–1408
Geerts WH (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl):338S–400S
Karthaus M (2006) Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 17(2):289–296
Verso M (2005) Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 23(18):4057–4062
Couban S (2005) Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 23(18):4063–4069
Biffi R (2004) Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol 15:296–300
Eastridge BJ, Lefor AT (1995) Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13:233–238
Magagnoli M (2005) Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients. Anticancer Res 25(4):3143–3147
Lyon RD, Griggs KA, Johnson AM, Olsen JR (1999) Long-term follow-up of upper extremity implanted venous access devices in oncology patients. J Vasc Interv Radiol 10:463–471
Mueller BU (1992) A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 10:1943–1948
Klerk CP, Smorenburg SM, Buller HR (2003) Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Arch Intern Med 163:1913–21
Kelly C (1992) A change in flushing protocols of central venous catheters. Oncol Nurs Forum 19:599–605
White RH, Zhou H, Romano PS (1998) Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism. Arch Intern Med 158:1005–1010
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karthaus, M. Prophylaxis of catheter-related venous thrombosis in cancer patients. Support Care Cancer 16, 787–790 (2008). https://doi.org/10.1007/s00520-007-0374-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-007-0374-0